Multiple Sclerosis Trial, Not Yet Recruiting NCT06672770 Sponsor: Selcuk University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT06672770
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Relapsing Remitting Multiple Sclerosis (RRMS), a type of MS where symptoms come and go in episodes.
  • People whose MS disability level falls within a specific range on a standard MS scale (EDSS score between 1 and 5), meaning some level of symptoms but still able to walk (confirm with trial site).
  • People who are able to speak, understand, read, and comprehend Turkish.
  • People who have not had an MS episode or attack in the last three months.
  • People who have not taken part in any breathing-based rehabilitation program in the last six months.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a neurological condition other than MS.
  • People who have restrictions on physical exercise due to their functional abilities.
  • People who have a chronic heart or lung condition — such as COPD, asthma, interstitial lung disease, or heart failure — that could affect breathing or breathing muscle strength.
  • People who have had pneumonia caused by a viral or bacterial infection in the last six months, or who have tested positive for COVID-19 on a PCR test.
  • People who have an orthopaedic problem, ongoing neck or back pain, or a related nerve pain condition that would prevent them from taking part in the study.
  • People who have been diagnosed with a psychiatric disorder.
  • People who currently use tobacco or tobacco-related products.
  • People who have difficulty cooperating with assessments or treatment in a way that would interfere with the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: İsmail ÖZSOY, Assoc. Prof. Dr., Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye

Phone: 5558175133

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Selcuk University
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
31 October 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Inspiratory Respiratory Muscle Strength; Expiratory Respiratory Muscle Strength; Respiratory Function (FEV₁); Respiratory Function (FVC); Respiratory Function (FEV₁/FVC); Respiratory Function (PEF); Respiratory Function (FEF%25-75); Respiratory Function (VC); Paced Auditory Serial Addition Test (PASAT); Symbol Digit Modalities Test (SDMT); Stroop Test; Walking; Balance; Functional Exercise Capacity; Physical Activity; Quality of Life; Core Muscles (Pelvic Bridge Test); Core Muscles (Modified Plank Test)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov